Oppenheimer analyst Steven Lichtman lowered the price target on Globus Medical (NYSE: GMED) to $78.00 (from $90.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Globus Medical (GMED) PT Lowered to $80 at Piper SandlerMay 9, 2025 10:20 AM Globus Medical (GMED) PT Lowered to $76 at Wells FargoMay 9, 2025 9:14 AM Globus Medical (GMED) PT Lowered to $68 at Truist Securities Following EPS MissMay 9, 2025 9:01 AM Globus Medical (GMED) PT Lowered to $70 at StifelMay 9, 2025 5:40 AM Globus Medical (GMED) PT Lowered to $77 at BTIGMay 9, 2025 5:35 AM Form 10-Q GLOBUS MEDICAL INC For: Mar 31May 8, 2025 5:19 PM Globus Medical (GMED) Misses Q1 EPS by 7c, Offers GuidanceMay 8, 2025 4:58 PM Form 8-K GLOBUS MEDICAL INC For: May 08May 8, 2025 4:18 PM Globus Medical Reports First Quarter 2025 ResultsMay 8, 2025 4:15 PM